April 18, 2024 | Asynchronous touchpoints, DOL engagement, HCP engagement, KOL Engagement, MSL engagement, Pharma engagement, Virtual Pharma, Virtual advisory board, digital advisory board, pharma innovation, pharma virtual meeting
Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today’s fast-paced digital environment.

Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today’s fast-paced digital environment.
4. Stay Pithy and On Point
In an era where distractions abound, the key to maintaining focus in virtual meetings is brevity. We recommend frequent, brief touchpoints rather than prolonged sessions to keep participants engaged. This approach aligns with findings from medical education that favour micro-learning. Additionally, when crafting asynchronous interactions, consider breaking longer questions into smaller, manageable parts (e.g., parts a, b, c) to streamline understanding and prevent participant fatigue. Stick to no more than three sub-questions per main question to keep clarity and minimize confusion.
This tip is part of our series on enhancing the effectiveness of both asynchronous and synchronous virtual interactions.
Explore our blog for more in-depth strategies and insights on optimizing your virtual meetings: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/
Deepen your engagement with Impetus Digital:
Follow us for the latest updates and insights:
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish…
Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey…
Jón Ingi Bergsteinsson, Co-founder & CCO at SMART-TRIAL, explores the barriers to, and benefits of, digitalization of clinical operations and trials in the MedTech industry, plus much more!
With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and…
Omri Shor, Co-founder & CEO of Medisafe, explores how Pharma companies can use digital therapeutics for advancing and supporting the patient journey, how new digital health tools are driving deeper…
Earlene Biggs, VP of Market Research & Analytics at ICON, explores best practices for life science market research and actionable analytics. She also shares her tips for creating organizational wellbeing…
Aubrey de Grey, Chief Science Officer at SENS Research Foundation, discusses a range of interesting topics surrounding innovative interventions and technologies that could not just postpone, but theoretically reverse, age-related…
At Impetus Digital, we pride ourselves with being the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight-synthesis. Our most popular service is online advisory boards. However, there is a myriad of…
Harry Glorikian, Author & General Partner at Scientia Ventures, dives into the current and future applications of AI and other innovative health technologies, including for personalized medicine, drug development, public…
Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson’s community catalyzed the founding of Charco and how innovative medical devices and software can improve…
